logo
Plus   Neg
Share
Email

Stock Alert: Co-Diagnostics Gains After Its Covid-19 Test Gets EUA

Shares of Co-Diagnostics, Inc. (CODX) are climbing more than 20% Monday morning after the molecular diagnostics company announced that its Logix Smart Coronavirus COVID-19 Test has obtained Emergency Use Authorization (EUA) from the FDA to be used for the diagnosis of SARS-CoV-2.

The company's COVID-19 test uses its proprietary CoPrimer technology to target the RdRp gene of the SARS-CoV-2 virus.

The company has started selling its new test kits to some U.S. CLIA labs in March as a result of FDA policy change in the current pandemic emergency.

Co-Diagnostics had already started selling the testing kits to Europe and to other global markets after the company won CE Mark from EU regulators in February.

CODX is currently trading at $9.92. It has traded in the range of $0.69- $21.75 in the past one year.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Latam Airlines Group SA, one of the largest air carrier in South America, has filed for bankruptcy protection in New York amid the ongoing Covid-19 pandemic, which has grounded flights worldwide. This Chapter 11 filing allows Latam to work with its creditors and other stakeholders to reduce its debt,... Pizza Hut said it is giving away 500,000 free pizzas to 2020 graduates in the Unites States. The pizza chain, owned by Yum! Brands, offers one free medium 1-topping pizza to all diploma/degree earning individuals until supplies last. The company is partnering with America's dairy farmers for the offer, which can be claimed until Thursday and redeemed until June 4. Merck & Co. Inc. on Tuesday announced deals, including an acquisition and two collaborations that will enable the U.S. drugmaker to join the race to develop coronavirus vaccines and drugs. Shares of Merck were rising almost 4 percent in the pre-market. Merck said it has agreed to acquire privately-held Themis, an Austria-based company focused on vaccines and immune-modulation therapies.
Follow RTT